首页> 外文期刊>The New Microbiologica >Use of T-SPOT.TB in latent tuberculosis infection diagnosis in general and immunosuppressed populations
【24h】

Use of T-SPOT.TB in latent tuberculosis infection diagnosis in general and immunosuppressed populations

机译:T-SPOT.TB在一般人群和免疫抑制人群中潜伏性结核感染诊断中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Immunosuppressed patients have a nine-fold greater risk of developing active tuberculosis (TB) disease given the latent TB infection than the general population. Few data are available on the predictivity of T-SPOT.TB in immunosuppressed patients. We had a T-SPOT.TB determination and a TST from 197 immunosuppressed haematological patients and 324 community contacts of infectious TB cases. In the general population, TST was positive in 275 (84.9%), T-SPOT.TB in 167 (51.5%) (p < 0.0001). In immunosuppressed patients, TST was positive in 34 (17.3%), T-SPOT.TB in 70 (35.5%). T-SPOT.TB is not influenced by immunosuppression and even an indeterminate result may yield useful information on patient's anergy.
机译:鉴于潜伏的TB感染,免疫抑制患者发生活动性结核(TB)的风险比普通人群高9倍。关于免疫抑制患者中T-SPOT.TB的可预测性的数据很少。我们对197例免疫抑制的血液病患者和324例感染性结核病例的社区接触者进行了T-SPOT.TB测定和TST。在总体人群中,TST阳性(275(84.9%)),T-SPOT.TB阳性(167(51.5%))(p <0.0001)。在免疫抑制的患者中,TST阳性的占34(17.3%),T-SPOT.TB阳性的占70(35.5%)。 T-SPOT.TB不受免疫抑制的影响,甚至不确定的结果也可能产生有关患者无反应性的有用信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号